Mark R. Cookson
Cell Biology and Gene Expression Section
Laboratory of Neurogenetics
National Institute on Aging
National Institutes of Health
USA
Name/email consistency: high
- Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease? Rudenko, I.N., Chia, R., Cookson, M.R. BMC. Med (2012)
- Parkinson's disease: insights from pathways. Cookson, M.R., Bandmann, O. Hum. Mol. Genet. (2010)
- DJ-1, PINK1, and their effects on mitochondrial pathways. Cookson, M.R. Mov. Disord. (2010)
- The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease. Cookson, M.R. Nat. Rev. Neurosci. (2010)
- alpha-Synuclein and neuronal cell death. Cookson, M.R. Mol. Neurodegener (2009)
- Cell systems and the toxic mechanism(s) of alpha-synuclein. Cookson, M.R., van der Brug, M. Exp. Neurol. (2008)
- Genetic neuropathology of Parkinson's disease. Cookson, M.R., Hardy, J., Lewis, P.A. International J. Clinical Experimental Pathology (2008)
- The roles of kinases in familial Parkinson's disease. Cookson, M.R., Dauer, W., Dawson, T., Fon, E.A., Guo, M., Shen, J. J. Neurosci. (2007)
- Hero versus antihero: the multiple roles of alpha-synuclein in neurodegeneration. Cookson, M.R. Exp. Neurol. (2006)
- The biochemistry of Parkinson's disease. Cookson, M.R. Annu. Rev. Biochem. (2005)
- How genetics research in Parkinson's disease is enhancing understanding of the common idiopathic forms of the disease. Cookson, M.R., Xiromerisiou, G., Singleton, A. Curr. Opin. Neurol. (2005)
- Molecules that cause or prevent Parkinson's disease. Cookson, M.R. PLoS Biol. (2004)
- Pathways to Parkinsonism. Cookson, M.R. Neuron (2003)
- Parkin's substrates and the pathways leading to neuronal damage. Cookson, M.R. Neuromolecular Med. (2003)
- Neurodegeneration: how does parkin prevent Parkinson's disease?. Cookson, M.R. Curr. Biol. (2003)
- Crystallizing ideas about Parkinson's disease. Cookson, M.R. Proc. Natl. Acad. Sci. U.S.A. (2003)